What happened, in summary

Chantal was 24 and already knew she carried a BRCA1 mutation when she felt a sudden painful lump during a beach trip. Just 1 month earlier, her preventive MRI had looked normal. Because the lump was visible and clearly new, she sought testing quickly. Biopsy confirmed aggressive Stage II triple-negative breast cancer. The stage was driven by local breast disease with lymph-node involvement, not distant spread. Treatment started fast. She received 4 rounds of a Red Devil chemotherapy regimen every other week, which caused severe nausea, constipation, bone pain, fatigue, low blood pressure, dizziness, and vomiting. She was then supposed to receive 12 weekly rounds of Taxol, but treatment stopped after about 4 weeks when her port catheter migrated into the tricuspid valve of her heart and triggered an emergency. The port was removed in mid-June, and she finished chemotherapy through her veins with carboplatin every 3 weeks. On August 30, 2021, she had a double mastectomy, lymph-node dissection, and tissue expanders placed. Four days later, dying skin from an allergic reaction to methylene blue dye forced another surgery to remove the expanders. Radiation followed after healing. Because of BRCA1 and her family history of ovarian cancer, she also had a total hysterectomy on October 12, 2021. As of December 2023, Chantal reported no current cancer and ongoing follow-up with her oncology team.